Researchers have found statin use significantly reduces the risk of hepatocellular carcinoma (HCC) and hepatic decompensation among patients with chronic liver disease (CLD). Statins, particularly lipophilic statins like atorvastatin and simvastatin, were associated with a substantial decrease in the likelihood of liver cancer and complications. Longer duration of statin use further increases this protective effect. Researchers conducted a historical cohort analysis of data from the Research Patient Data Registry, clinical data from hospitals within the Mass General Brigham health care system, covering 2000-2023. Participants included 16,501 adult patients aged 40 or older diagnosed with CLD and a baseline Fibrosis-4 (FIB-4)...